论文部分内容阅读
本品系由半枝莲、七叶一枝花、山茨菇、仙鹤草、莪术等多味中药与氟脲嘧啶经加工配制提取而成的中西药复方口服片剂。广州中医学院肿瘤研究室、中山医学院肝癌研究室、广州市医药工业研究所以及广州中药三厂共同协作研究,依据肝癌的病理机制和多年治疗原发性肝癌的临床实践,采用有传统记载及经药理试验有抑癌作用的中药,配合小剂量化学药物制成本品。药理研究和临床试验表明,本品对肝癌患者有一定的疗效,且未见明显副作用,服用方便。于1982年通过了鉴定。
This product is a combination of traditional Chinese and Western medicine oral tablets, which are prepared from the herbs of Scutellaria barbata, Aesculus fragrans, S. esculenta, Agrimonia pygmaea, Curcuma zedoaria, and fluorouracil. The joint research of the Cancer Research Center of Guangzhou University of Traditional Chinese Medicine, the Hepatocellular Research Laboratory of Zhongshan Medical College, the Guangzhou Institute of Pharmaceutical Industry, and the Third Factory of Traditional Chinese Medicine in Guangzhou used traditional records and based on the pathological mechanism of liver cancer and the clinical practice of treating liver cancer for many years. The pharmacological test has anti-cancer effect of Chinese medicine, with a small dose of chemical drugs made of this product. Pharmacological studies and clinical trials have shown that this product has a certain effect on liver cancer patients, and no obvious side effects, easy to take. In 1982 passed the appraisal.